Riskpilot← Back to searchSign inGet full accessMedviso AB
ABActiveOrg 5567385595Griffelvägen 3Other software publishing · NACE 5829Est. 20077 employees
Revenue 2025
SEK 4,1M
+9% vs 2024
EBITDA margin
-12.6%
-65% vs 2024
Equity ratio
23.7%
Financial strength
Net profit 2025
SEK -356K
-28% vs 2024
| Revenue | SEK 4,1M | +9% |
| EBITDA | SEK -517K | -65% |
| Net profit | SEK -356K | -28% |
| Total assets | SEK 2,4M | -11% |
| Equity | SEK 577K | -38% |
| Employees | 7 | — |
Legal name
Medviso AB
Org number
5567385595
Legal form
Aktiebolag
NACE code
5829 · Other software publishing
Founded
20 september 2007
Share capital
SEK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall utveckla och sälja programvara för analys av medicinska bilder och i synnerhet kardiovaskulära applikationer, ge konsultationer, hjälp med bilddiagnostik, utbildningar och uppdragsutveckling, ha en stark forskningsanknytning genom att följa och stödja forskningen inom området samt idka därmed förenlig verksamhet.
Address
Griffelvägen 3
Email
info@medviso.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 561 | 1 915 | 1 950 | 2 896 | 3 648 | 4 159 | 3 786 | 4 111 |
| Staff expenses | — | — | — | — | — | — | −2 622 | −3 394 | −3 444 | −3 549 |
| EBITDA | 86 | 287 | 632 | −883 | −28 | 133 | −43 | −198 | −314 | −517 |
| Depreciation & amort. | −0 | −16 | −0 | −0 | −0 | −0 | — | — | — | — |
| EBIT | 86 | 271 | 632 | −883 | −28 | 133 | −43 | −198 | −314 | −517 |
| Net financials | — | −1 | −1 | — | — | — | — | 3 | 34 | 161 |
| Profit before tax | 86 | 202 | 472 | −655 | −28 | 133 | −43 | −195 | −279 | −356 |
| Tax | −8 | −45 | −106 | −0 | −0 | −0 | — | — | — | — |
| Net profit | 78 | 157 | 366 | −655 | −28 | 133 | −43 | −195 | −279 | −356 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 061 | 1 482 | 2 212 | 1 150 | 1 873 | 2 093 | 2 385 | 2 232 | 2 738 | 2 435 |
| Equity | 478 | 635 | 1 001 | 346 | 317 | 450 | 407 | 212 | 933 | 577 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — |
| Short-term debt | 583 | 779 | 983 | 805 | 1 454 | 1 462 | 1 750 | 1 743 | 1 489 | 1 396 |
| Total debt | 583 | 779 | 983 | 805 | 1 454 | 1 462 | 1 750 | 1 743 | 1 489 | 1 396 |
EBITDA margin
-12.6%
This company
15.8%
Market median
-180% vs market
20162025
Equity ratio
23.7%
This company
38.2%
Market median
-38% vs market
20162025
Return on equity
-61.8%
This company
18.4%
Market median
-436% vs market
20162025
Net profit margin
-8.7%
This company
8.1%
Market median
-207% vs market
20162025
Asset turnover
1.69×
This company
1.12×
Market median
+51% vs market
20162025
Debt / equity
3.22×
This company
0.62×
Market median
-419% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
JD Audit | Audit | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medviso AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Helen Fransson | Chief Executive Officer | 0 companies |
| Jimmy Do | Audit | 0 companies |
| Clas Gunnar Runnberg | Board of Directors | 0 companies |
| Kristina Maria Arheden | Board of Directors | 0 companies |
| Einar Karl Brandt | Chairman | 0 companies |